New Delhi, Mar 28 (PTI): The Supreme Court has deprecated in "strongest terms" the disclosure of identity of a girl in a rape case and directed all high courts to ensure that names of survivors and their family members are not mentioned in court orders.
In its 2018 judgement in the Nipun Saxena case, the top court had said, "No person can print or publish in print, electronic, social media, etc. the name of the victim or even in a remote manner disclose any facts which can lead to the victim being identified and which should make her identity known to the public at large."
A bench of Justices Sanjay Karol and N Kotiswar Singh attributed lapses in following the ruling to the general indifference of the courts and "possibly even" the lack of awareness of the deep stigma that follows such offences.
The top court said that the legislature in 1983 introduced a provision to the IPC seeking to protect the identity of the of the victim of the offence under Section 376 Indian Penal Code.
ALSO READ: Goa sex scandal in which councillor's son has been arrested has more than 100 victims: Cong leader
The amendment, it said, was made apparently to address a specific mischief that emerged starkly from the way sexual offence cases were handled: the public disclosure of a survivor's identity.
The bench thus directed that a copy of the judgment be sent to all the high court registrars general.
It also mentioned Section 228A of the Indian Penal Code, 1860, which prohibits the disclosure of the identity of victims of sexual offences, including rape, to prevent social stigma.
"This has been the long-standing position in law, but it has not been followed. The primary reason there amongst, one supposes, is the general indifference of the courts below and possibly even the lack of awareness of the deep stigma that follows such offences," the bench said.
The observations came while setting aside an order of the Himachal Pradesh High Court, which reversed the conviction of a man in the rape of a nine-year-old girl, saying courts must not give undue importance to minor discrepancies.
ALSO READ: Rupali Chakankar resigns as NCP state women's wing chief
The top court said that before 1983, there was no statutory bar on publishing the name or particulars of a female sexual assault victim, alleged or proven, and court reporting and media coverage could expose survivors to social stigma, ostracism, and lifelong reputational harm.
"Clearly, the intent of this section has been given a miss in these proceedings. The name of the victim is treated like that of any other witness and is freely used throughout the record. This must be deprecated in the strongest terms. In fact, this court has noticed earlier also that the mandate of this provision is not being followed," the bench said.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
New Delhi: India reported an estimated 2.7 million tuberculosis cases in 2025 which translates into an incidence of 185 cases per 100,000 population, according to the latest official update on the disease burden.
The figure is more than four times the elimination benchmark set under the National Strategic Plan for Tuberculosis. The plan had aimed to bring down incidence to 44 cases per 100,000 population and mortality to three per 100,000 by 2025. The target was announced in March 2017 and was set five years ahead of the global End TB goals and the UN Sustainable Development Goals.
Data indicate that TB notifications have increased by 13 per cent compared to pre-Covid levels, as IndiaSpend reported in July 2025. Public health experts have said higher notification does not necessarily reflect a rise in incidence, but indicate improved case detection. Authorities have stepped up efforts to improve reporting and plug gaps in diagnosis and treatment, under the National Tuberculosis Elimination Programme (NTEP).
According to a 2019 study published in PLOS Medicine, the most substantial gap occurs during the testing stage, with nearly half of those with incident tuberculosis not receiving diagnostic tests. Experts say stigma, restricted availability to molecular testing, and dependence on sputum microscopy continue to impede early detection.
According to official data, 19.3 million smear microscopy tests were performed in 2023, compared to 6.83 million molecular tests using the CBNAAT/GeneXpert and Truenat platforms, indicating that smear-based diagnosis will continue to be used. While doctors report inconsistent implementation across regions, legislation mandates 100% molecular testing for suspected tuberculosis patients.
Health officials point to the increase of diagnostic infrastructure, which includes approximately 10,000 Nucleic Acid Amplification Test equipment and over 25,000 microscopy centers across the country. Eexperts identify operational difficulties such as specimen transportation, machine maintenance, supplier chains, and unequal distribution of skilled staff.
Under the TB-Mukt Bharat Abhiyan, the government has expanded active case-finding in high-risk areas and identified 1.58 lakh vulnerable villages and urban wards using an AI-based mapping tool. Under which the latest campaign document states that of the 2.73 million cases reported in 2025, 35 per cent were asymptomatic.
Specialists warn that up to half of microbiologically diagnosed pulmonary tuberculosis patients may not show characteristic symptoms, contributing to continuous community transmission. To increase early diagnosis of drug resistance, it is advised that chest X-rays and molecular testing be used more frequently.
Specialists warn that up to half of microbiologically diagnosed pulmonary tuberculosis patients may not show characteristic symptoms, contributing to continuous community transmission. To increase early diagnosis of drug resistance, it is advised that chest X-rays and molecular testing be used more frequently.
The government increased financial aid for Tuberculosis patients under the Nikshay Poshan Yojana to ₹1,000 per month, as the disease is mostly linked with malnutrition and poor living conditions and those with a BMI less than 18.5 are given energy-dense nutritional supplements for the first two months of therapy.
